Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

5.1K
5.1K
Proteoglycans01:05

Proteoglycans

3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

2.2K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.2K
Cross-bridge Cycle01:26

Cross-bridge Cycle

117.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fat aspiration for amyloidosis screening of 2830 patients from 2013 to 2020: compelling sensitivity for AL and better sensitivity in females for all major subtypes.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026
Same author

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Clinical kidney journal·2026
Same author

Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.

Bone marrow transplantation·2026
Same author

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases.

HemaSphere·2026
Same author

Retrospective cohort study of treatment with BCL-2 inhibitor venetoclax in advanced AL amyloidosis.

Haematologica·2026
Same author

First-Generation TTR Silencing Therapies in Hereditary Transthyretin Amyloidosis With Polyneuropathy: Real-World Insights From a German Single-Referral Center.

European journal of neurology·2026

Related Experiment Video

Updated: Jun 11, 2025

Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.2K

[Amyloidosis].

Ute Hegenbart, Kiavasch M N Farid, Stefan Schönland

    Deutsche Medizinische Wochenschrift (1946)
    |October 9, 2024
    PubMed
    Summary

    Amyloidosis, rare protein misfolding diseases, are treatable. Early diagnosis and prompt treatment are crucial, especially for heart involvement, to prevent irreversible organ damage and improve patient outcomes.

    Area of Science:

    • Rare protein misfolding and deposition diseases.
    • Involves the abnormal accumulation of proteins in organs.
    • Impacts multiple organ systems, including the heart.

    Context:

    • Amyloidosis prognosis is highly dependent on the specific form and organ involvement.
    • Cardiac amyloidosis often presents late, leading to poor outcomes.
    • Delayed diagnosis significantly worsens patient survival and organ function.

    Purpose:

    • To highlight the importance of timely diagnosis and treatment for amyloidosis.
    • To emphasize the critical role of specialized amyloidosis centers.
    • To underscore the need for prompt intervention in managing amyloidosis.

    Summary:

    • Amyloidosis encompasses rare diseases characterized by protein misfolding and deposition.

    More Related Videos

    Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
    10:04

    Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

    Published on: October 20, 2017

    13.4K
    Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
    08:25

    Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

    Published on: April 19, 2021

    3.2K

    Related Experiment Videos

    Last Updated: Jun 11, 2025

    Rapid Generation of Amyloid from Native Proteins In vitro
    05:48

    Rapid Generation of Amyloid from Native Proteins In vitro

    Published on: December 5, 2013

    6.2K
    Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
    10:04

    Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

    Published on: October 20, 2017

    13.4K
    Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
    08:25

    Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

    Published on: April 19, 2021

    3.2K
  • While many forms are treatable, cardiac involvement carries a poor prognosis if diagnosed late.
  • Immediate treatment initiation post-diagnosis is vital for preserving organ function.

    • Impact:

    • Early detection and treatment can prevent irreversible organ damage.
    • Specialized centers facilitate diagnosis, treatment development, and clinical trials.
    • Improved management strategies are essential for enhancing survival rates in amyloidosis patients.